Showing results (181-190 of 5,496) with videos related to

Sort By:
Pageof 550
Inflammatory Bowel Diseases|May 4, 2006
Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric studyAlessandro Ferraris, Barbara Torres, Daniela Knafelz, et al.
Inflammatory Bowel Diseases|May 4, 2006
Critical role of IL-17 receptor signaling in acute TNBS-induced colitisZili Zhang, Mingquan Zheng, Julie Bindas, et al.
Inflammatory Bowel Diseases|May 4, 2006
Regulation of apoptosis during homeostasis and disease in the intestinal epitheliumKaren L Edelblum, Fang Yan, Toshimitsu Yamaoka, et al.
Inflammatory Bowel Diseases|December 1, 2007
Campylobacter and IFNgamma interact to cause a rapid loss of epithelial barrier integrityLouisa E N Rees, Tristan A Cogan, Amanda L Dodson, et al.
Inflammatory Bowel Diseases|December 1, 2007
Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in childrenMarc A Sidler, Steven T Leach, Andrew S Day
Inflammatory Bowel Diseases|February 21, 2002
Metastatic Crohn's disease of the foreheadLivia Biancone, Karel Geboes, Luigi G Spagnoli, et al.
Inflammatory Bowel Diseases|December 4, 1998
Interpretation of bone mineral density values in pediatric Crohn's diseaseD Herzog, N Bishop, F Glorieux, et al.
Inflammatory Bowel Diseases|December 4, 1998
The implications of acute pouchitis on the long-term functional results after restorative proctocolectomyR D Hurst, T P Chung, M Rubin, et al.
Inflammatory Bowel Diseases|May 20, 2008
Clostridium difficile and inflammatory bowel diseaseMazen Issa, Ashwin N Ananthakrishnan, David G Binion
Inflammatory Bowel Diseases|May 20, 2008
Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's diseaseTaina Sipponen, Erkki Savilahti, Päivi Kärkkäinen, et al.
Pageof 550